IDEAS home Printed from https://ideas.repec.org/a/adm/journl/v11y2022i2p29-38.html
   My bibliography  Save this article

Construction of a Natural Human Fab Phage Antibody Library and Screening of Phage Antibody against PD-L1

Author

Listed:
  • Jiangtao Gu
  • Raoqing Guo
  • Ligang Zhang
  • Ning Deng

Abstract

Programmed Death Ligand-1(PD-L1) is an important target to drive T cell dysfunction when it connects with Programmed Death-1(PD-1), leading to immune escape of tumor cells, thus anti-PD-L1 antibody shows a promising prospect in the treatment of tumor. In order to construct a large natural antibody library, we collected a large number of lymphocytes of adults and children. The light chain and Fd genes of antibody were amplified by PCR, and the Fab phage antibody library with a library capacity of 4.27×109 was constructed. The insertion rates of the light chain library and the Fab library were 90% and 70%, respectively. The cloned sequences identified by PCR showed that all the sequences analyzed were unique, and the amino acid sequences of the CDR regions were diverse, which proved that there was good diversity in the antibody library. The positive clones that bind to PD-L1 were screened by phage ELISA, PCR identification and sequence analysis. In the end, two high-affinity positive clones were determined. The successful construction of this natural phage antibody library provided an effective method for screening human PD-L1 antibodies, which was expected to screen humanized antibodies against various antigens.

Suggested Citation

  • Jiangtao Gu & Raoqing Guo & Ligang Zhang & Ning Deng, 2022. "Construction of a Natural Human Fab Phage Antibody Library and Screening of Phage Antibody against PD-L1," International Journal of Sciences, Office ijSciences, vol. 11(02), pages 29-38, February.
  • Handle: RePEc:adm:journl:v:11:y:2022:i:2:p:29-38
    DOI: 10.18483/ijSci.2561
    as

    Download full text from publisher

    File URL: https://www.ijsciences.com/pub/article/2561
    Download Restriction: no

    File URL: https://www.ijsciences.com/pub/pdf/V112022022561.pdf
    Download Restriction: no

    File URL: https://libkey.io/10.18483/ijSci.2561?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Ira Mellman & George Coukos & Glenn Dranoff, 2011. "Cancer immunotherapy comes of age," Nature, Nature, vol. 480(7378), pages 480-489, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Maria Pia Lenza & Leire Egia-Mendikute & Asier Antoñana-Vildosola & Cátia O. Soares & Helena Coelho & Francisco Corzana & Alexandre Bosch & Prodhi Manisha & Jon Imanol Quintana & Iker Oyenarte & Luca , 2023. "Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    2. Zhiren Wang & Wenpan Li & Yanhao Jiang & Tuyen Ba Tran & Leyla Estrella Cordova & Jinha Chung & Minhyeok Kim & Georg Wondrak & Jennifer Erdrich & Jianqin Lu, 2023. "Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    3. Wenquan Ou & Samantha Stewart & Alisa White & Elyahb A. Kwizera & Jiangsheng Xu & Yuanzhang Fang & James G. Shamul & Changqing Xie & Suliat Nurudeen & Nikki P. Tirada & Xiongbin Lu & Katherine H. R. T, 2023. "In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    4. Yanjuan Huang & Zilin Guan & Xiuling Dai & Yifeng Shen & Qin Wei & Lingling Ren & Jingwen Jiang & Zhanghong Xiao & Yali Jiang & Di Liu & Zeqian Huang & Xiaoyu Xu & Yong Luo & Chunshun Zhao, 2021. "Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer," Nature Communications, Nature, vol. 12(1), pages 1-22, December.
    5. Ikuko Taira & Yuichiro Taira & Masakazu Kato & Yoshimi Shimizu & Katuhiro Isoda & Hiromi Saitou & Isao Ishida, 2019. "Reviving Previous Therapeutics by Recombinant Anaerobic Bifidobacteria," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 12(5), pages 9596-9601, January.
    6. Dzana Dervovic & Ahmad A. Malik & Edward L. Y. Chen & Masahiro Narimatsu & Nina Adler & Somaieh Afiuni-Zadeh & Dagmar Krenbek & Sebastien Martinez & Ricky Tsai & Jonathan Boucher & Jacob M. Berman & K, 2023. "In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    7. Nailin Yang & Fei Gong & Bo Liu & Yu Hao & Yu Chao & Huali Lei & Xiaoyuan Yang & Yuehan Gong & Xianwen Wang & Zhuang Liu & Liang Cheng, 2022. "Magnesium galvanic cells produce hydrogen and modulate the tumor microenvironment to inhibit cancer growth," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    8. Ghanizadeh, Mojtaba & Shariatpanahi, Seyed Peyman & Goliaei, Bahram & Rüegg, Curzio, 2021. "Mathematical modeling approach of cancer immunoediting reveals new insights in targeted-therapy and timing plan of cancer treatment," Chaos, Solitons & Fractals, Elsevier, vol. 152(C).
    9. Joonsu Han & Rimsha Bhatta & Yusheng Liu & Yang Bo & Alberto Elosegui-Artola & Hua Wang, 2023. "Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    10. Jingchao Li & Yu Luo & Ziling Zeng & Dong Cui & Jiaguo Huang & Chenjie Xu & Liping Li & Kanyi Pu & Ruiping Zhang, 2022. "Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles," Nature Communications, Nature, vol. 13(1), pages 1-15, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adm:journl:v:11:y:2022:i:2:p:29-38. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Staff ijSciences (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.